Healthcare Government Regulation News

"US Agencies Investigate Middlemen's Role in Critical Generic Drug Shortages"

The FTC and HHS have issued a Request for Information seeking public comment on how group purchasing organizations (GPOs) and drug wholesalers may be contributing to generic drug shortages. They are investigating market concentration, contracting practices, and the impact on pricing and availability of pharmaceutical drugs. The inquiry aims to uncover the root causes and potential solutions to drug shortages, with a focus on promoting competition in pharmaceutical markets to ensure access to high-quality, affordable care. The public has 60 days to submit comments on several topics related to generic drug markets and potential causes of shortages.